Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard Safran

Showing results (71-80 of 117) with videos related to

Pageof 12
Sort By:
Cancer Biology & Therapy|December 3, 2021
Combination of ONC201 and TLY012 induces selective, synergistic apoptosis in vitro and significantly delays PDAC xenograft growth in vivoAakash V Jhaveri, Lanlan Zhou, Marie D Ralff, et al.
Neuro-Oncology Advances|April 11, 2022
Malignant glioma subset from actuate 1801: Phase I/II study of 9-ING-41, GSK-3β inhibitor, monotherapy or combined with chemotherapy for refractory malignanciesYazmin Odia, Ludimila Cavalcante, Howard Safran, et al.
Future Oncology (London, England)|February 11, 2022
Long-term avelumab in advanced non-small-cell lung cancer: summaries and <i>post hoc</i> analyses from JAVELIN Solid TumorBorys Hrinczenko, Nicholas Iannotti, Sanjay Goel, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 2011
Failure to adhere to protocol specified radiation therapy guidelines was associated with decreased survival in RTOG 9704--a phase III trial of adjuvant chemotherapy and chemoradiotherapy for patients with resected adenocarcinoma of the pancreasRoss A Abrams, Kathryn A Winter, William F Regine, et al.
Journal of Oncology Practice|February 25, 2016
Clinical Trial Accrual Targeting Genomic Alterations After Next-Generation Sequencing at a Non-National Cancer Institute-Designated Cancer ProgramKalyan C Mantripragada, Adam J Olszewski, Andrew Schumacher, et al.
American Journal of Clinical Oncology|April 24, 2014
Lapatinib and gemcitabine for metastatic pancreatic cancer. A phase II studyHoward Safran, Thomas Miner, Nathan Bahary, et al.
International Journal of Radiation Oncology, Biology, Physics|January 5, 2016
RECQ1 A159C Polymorphism Is Associated With Overall Survival of Patients With Resected Pancreatic Cancer: A Replication Study in NRG Oncology Radiation Therapy Oncology Group 9704Donghui Li, Jennifer Moughan, Christopher Crane, et al.
International Journal of Radiation Oncology, Biology, Physics|May 4, 2018
Tolerability of ADXS11-001 Lm-LLO Listeria-Based Immunotherapy With Mitomycin, Fluorouracil, and Radiation for Anal CancerHoward Safran, Kara-Lynne Leonard, Kimberly Perez, et al.
Clinical Journal of Oncology Nursing|January 20, 2018
Prechemotherapy Education: Reducing Patient Anxiety Through Nurse-Led Teaching Sessions
Emmanuel Apor, Nathan T Connell, Katherine Faricy-Anderson, et al.
Molecular Aspects of Medicine|April 20, 2026
Advancing precision medicine in pancreatic cancer using novel biomarkers and clinical targetsDivya Murthy, Attila A Seyhan, Petra den Hollander, et al.
Pageof 12

Showing results (71-80 of 117) with videos related to

Sort By:
Pageof 12
Cancer Biology & Therapy|December 3, 2021
Combination of ONC201 and TLY012 induces selective, synergistic apoptosis in vitro and significantly delays PDAC xenograft growth in vivoAakash V Jhaveri, Lanlan Zhou, Marie D Ralff, et al.
Neuro-Oncology Advances|April 11, 2022
Malignant glioma subset from actuate 1801: Phase I/II study of 9-ING-41, GSK-3β inhibitor, monotherapy or combined with chemotherapy for refractory malignanciesYazmin Odia, Ludimila Cavalcante, Howard Safran, et al.
Future Oncology (London, England)|February 11, 2022
Long-term avelumab in advanced non-small-cell lung cancer: summaries and <i>post hoc</i> analyses from JAVELIN Solid TumorBorys Hrinczenko, Nicholas Iannotti, Sanjay Goel, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 2011
Failure to adhere to protocol specified radiation therapy guidelines was associated with decreased survival in RTOG 9704--a phase III trial of adjuvant chemotherapy and chemoradiotherapy for patients with resected adenocarcinoma of the pancreasRoss A Abrams, Kathryn A Winter, William F Regine, et al.
Journal of Oncology Practice|February 25, 2016
Clinical Trial Accrual Targeting Genomic Alterations After Next-Generation Sequencing at a Non-National Cancer Institute-Designated Cancer ProgramKalyan C Mantripragada, Adam J Olszewski, Andrew Schumacher, et al.
American Journal of Clinical Oncology|April 24, 2014
Lapatinib and gemcitabine for metastatic pancreatic cancer. A phase II studyHoward Safran, Thomas Miner, Nathan Bahary, et al.
International Journal of Radiation Oncology, Biology, Physics|January 5, 2016
RECQ1 A159C Polymorphism Is Associated With Overall Survival of Patients With Resected Pancreatic Cancer: A Replication Study in NRG Oncology Radiation Therapy Oncology Group 9704Donghui Li, Jennifer Moughan, Christopher Crane, et al.
International Journal of Radiation Oncology, Biology, Physics|May 4, 2018
Tolerability of ADXS11-001 Lm-LLO Listeria-Based Immunotherapy With Mitomycin, Fluorouracil, and Radiation for Anal CancerHoward Safran, Kara-Lynne Leonard, Kimberly Perez, et al.
Clinical Journal of Oncology Nursing|January 20, 2018
Prechemotherapy Education: Reducing Patient Anxiety Through Nurse-Led Teaching Sessions
Emmanuel Apor, Nathan T Connell, Katherine Faricy-Anderson, et al.
Molecular Aspects of Medicine|April 20, 2026
Advancing precision medicine in pancreatic cancer using novel biomarkers and clinical targetsDivya Murthy, Attila A Seyhan, Petra den Hollander, et al.
Pageof 12